Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Doxycycline
Drug ID BADD_D00725
Description Doxycycline is a broad-spectrum antibiotic synthetically derived from oxytetracycline [FDA label]. This drug is a second-generation tetracycline, exhibiting lesser toxicity than first-generation tetracyclines [A174034]. Doxycycline may be used to treat a wide range of bacterial infections, depending on the results of antibiotic susceptibility testing.
Indications and Usage Not Available
Marketing Status Prescription; Discontinued
ATC Code A01AB22; J01AA02
DrugBank ID DB00254
KEGG ID D00307
MeSH ID D004318
PubChem ID 54671203
TTD Drug ID D0S0LZ
NDC Product Code 63629-8212; 71205-616; 65841-823; 23155-133; 70934-085; 65841-822; 43063-985; 72789-199; 27808-233; 70934-178; 71335-0823; 50090-4833; 43063-886; 68180-657; 0713-0554; 40032-790; 67296-1368; 42291-156; 0713-0572; 55700-122; 43386-790; 68382-706; 50909-8106; 60219-1100; 67457-437; 0527-1535; 46708-249; 68180-651; 0527-1335; 70710-1124; 68084-743; 0299-3822; 55018-164; 53002-0673; 70710-1123; 67296-1385; 70771-1006; 0527-1338; 63304-615; 71610-220; 11014-0092; 49884-726; 50268-281; 61919-474; 70771-1008; 70518-0213; 68999-417; 40032-792; 70934-808; 50090-4592; 60687-344; 70710-1122; 0713-0571; 63304-130; 46708-250; 51407-387; 49884-727; 63187-672; 43386-791; 68180-652; 68382-782; 63629-2183; 0713-0570; 70518-3365; 69097-228; 63304-616; 68382-707; 63629-7751; 72189-006; 62135-417; 62332-249; 50090-1787; 63323-130; 67296-1762; 70771-1007; 67296-1025; 70710-1121; 63304-614; 70934-325; 52584-437; 63304-132; 0713-0555; 0404-9855; 62332-250; 66993-815; 23155-136; 43386-792; 65841-821; 55488-0200; 63187-936; 23155-135; 69238-1100; 49884-305; 0069-0970; 47621-017; 67296-1570; 68382-911; 50268-280; 71335-1988; 50090-3809; 50090-4599; 68071-2617; 72789-047; 67296-1688; 71335-1479; 40032-791; 63187-712; 71205-135; 63187-135; 69238-1500; 63304-173; 70771-1121; 68382-910; 0527-1537; 71335-0436; 50090-1472; 61919-433; 68071-4354; 69988-0020; 70771-1122; 71335-0861; 54348-573; 67296-1674; 0115-1327; 53002-0671; 61919-276; 55700-723; 53002-0672; 59929-631; 63629-7970; 70518-0187; 23155-134; 69238-1501; 70771-1009; 71205-385; 63304-131; 0143-9381; 68180-650; 70934-499
Synonyms Doxycycline | Doxycycline Monohydrate | Vibramycin | Atridox | Doxycycline Phosphate (1:1) | BMY-28689 | BMY 28689 | BMY28689 | BU-3839T | BU 3839T | BU3839T | Doryx | Doxycycline Calcium Salt (1:2) | Doxycycline Hyclate | Doxycycline Hemiethanolate | Doxycycline Monohydrochloride, 6-epimer | Doxycycline Monohydrochloride, 6 epimer | Doxycycline Monohydrochloride, Dihydrate | Doxycycline Calcium | 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S-(4alpha,4aalpha,5alpha,5aalpha,6alpha,12aalpha))- | Alpha-6-Deoxyoxytetracycline | Alpha 6 Deoxyoxytetracycline | Doxycycline-Chinoin | Doxycycline Chinoin | Hydramycin | Oracea | Periostat | Vibra-Tabs | Vibra Tabs | Vibramycin Novum | Vibravenos
Chemical Information
Molecular Formula C22H24N2O8
CAS Registry Number 564-25-0
SMILES CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Toothache07.09.06.001--
Toxic epidermal necrolysis23.03.01.008; 12.03.01.015; 11.07.01.006; 10.01.01.006--
Ulcer08.03.06.001--Not Available
Urticaria10.01.06.001; 23.04.02.0010.000210%
Vaginal infection21.14.02.002; 11.01.10.002--
Vascular purpura24.07.06.011; 23.06.01.008; 01.01.04.007--Not Available
Vision blurred17.17.01.010; 06.02.06.0070.000157%
Vomiting07.01.07.0030.000315%
Vulvovaginal candidiasis11.03.03.005; 21.14.02.003--Not Available
Weight decreased13.15.01.0050.000105%
Osteopenia15.02.03.003; 14.04.04.004--Not Available
Contusion15.03.01.008; 12.01.06.001; 24.07.06.001; 23.03.11.0020.000105%
Necrotising colitis07.08.01.013--Not Available
Musculoskeletal discomfort15.03.04.001--Not Available
Angiopathy24.03.02.0070.000105%Not Available
Epidermal necrosis23.03.03.035--Not Available
Inflammation08.01.05.007--Not Available
Decreased appetite08.01.09.028; 14.03.01.005--
Ill-defined disorder08.01.03.049--Not Available
Drug intolerance08.06.01.0130.000157%Not Available
Pigmentation disorder23.05.03.001--Not Available
Vaginitis bacterial21.14.02.010; 11.02.01.020--Not Available
Tooth fracture12.01.09.010; 07.09.05.008--Not Available
Vulvovaginal mycotic infection21.14.02.004; 11.03.05.004--Not Available
Oropharyngeal discomfort07.05.05.008; 22.02.05.027--Not Available
Oropharyngeal pain22.02.05.022; 07.05.05.004--
Acute kidney injury20.01.03.0160.000105%
Upper-airway cough syndrome22.02.05.030--
Drug-induced liver injury12.03.01.044; 09.01.07.0230.000157%Not Available
Multiple organ dysfunction syndrome08.01.03.0570.000027%
The 6th Page    First    Pre   6 7    Next   Last    Total 7 Pages